Literature DB >> 8932938

Revision surgery in otosclerosis--an investigation of the factors which influence the hearing result.

C B Pedersen1.   

Abstract

The hearing improvement obtained by revision surgery for otosclerosis has been assessed in 163 patients with a conductive hearing loss. Several different surgical techniques had been used at the primary operation. On average at revision a hearing improvement of 11 dB was obtained. The hearing improvement was related to the surgical technique of the primary operation, the middle ear abnormalities and the surgical technique used at revision. Patients in whom a small-fenestra-technique had been used for the primary as well as the revision procedure, had a better result than patients who had total removal of the footplate. Patients with adhesions and an eccentric prosthesis only showed a small hearing improvement. Patients with necrosis of the long process of the incus were also difficult to manage. Since the complication rate was low it does not seem to be more dangerous to perform a revision than to perform a primary operation. The results obtained by revision are poorer than can be obtained by the primary procedure. This indicates that in stapes surgery the greatest chance for hearing improvement is the first operation, therefore centralization of this type of operation should be considered.

Entities:  

Mesh:

Year:  1996        PMID: 8932938     DOI: 10.1046/j.1365-2273.1996.00792.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  2 in total

1.  Revision Stapedotomies: The Role of Periprosthetic Scar Tissue Formation in the Development of Unsatisfactory Hearing Results after Stapedotomy.

Authors:  Gábor Polony; Anita Gáborján; László Tamás; László Székely
Journal:  Int Arch Otorhinolaryngol       Date:  2021-12-13

2.  The Relationship between Stapes Prosthesis Length and Rate of Stapedectomy Success.

Authors:  Cinzia L Marchica; Issam Saliba
Journal:  Clin Med Insights Ear Nose Throat       Date:  2015-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.